Takuo Matsukawa
Kitakyushu, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
Real-world Outcomes of First-line Platinum-based Chemotherapy in Patients Aged 80 Years or Older With Metastatic Urothelial Carcinoma.
Journal: Cancer diagnosis & prognosis
Published: May 11, 2026
Reduced Uncoupling Protein 1 Expression in Periprostatic Adipose Tissue and Its Association With Higher Prostate Cancer Grade.
Journal: International journal of urology : official journal of the Japanese Urological Association
Published: March 22, 2026
Role of Latrophilin-1 and Latrophilin-2 as Downstream Effectors of Androgen Receptor Signaling in Urothelial Tumorigenesis.
Journal: Cancer reports (Hoboken, N.J.)
Published: January 30, 2026
Recurrence of Low-risk Non-muscle-invasive Bladder Cancer in Patients Who Did Not Receive Immediate Intravesical Chemotherapy.
Journal: Cancer diagnosis & prognosis
Published: October 11, 2025
Immune Checkpoint Inhibitor Retreatment after Enfortumab Vedotin in Advanced Urothelial Carcinoma: A Descriptive Study with Exploratory Evaluation of Radiotherapy.
Journal: JMA journal
Published: September 22, 2025
Expression of Glucocorticoid Receptor and FOXO1/phospho-FOXO1 in Bladder Cancer as Independent Prognosticators.
Journal: Cancer genomics & proteomics
Published: July 21, 2025
Visfatin Promotes Renal Cell Carcinoma Progression: Evidence from Clinical Samples and Cell Line Models.
Journal: Journal of kidney cancer and VHL
Published: June 25, 2025
Pioglitazone Suppresses Urothelial Tumorigenesis In Vitro: A Potential Chemopreventive Agent.
Journal: Cancer genomics & proteomics
Published: June 16, 2025
Prostate-specific Antigen Decline During Primary Androgen-deprivation Therapy for Predicting Response and Survival in Metastatic Castration-resistant Prostate Cancer Patients Receiving Enzalutamide.
Journal: In vivo (Athens, Greece)
Published: March 19, 2025
Survival and Safety Outcomes of Avelumab Maintenance Therapy for Advanced Urothelial Carcinoma from a Single-Center Experience.
Journal: In vivo (Athens, Greece)
Published: February 15, 2025
Clinical significance of the dose modification of enfortumab vedotin monotherapy for advanced urothelial carcinoma.
Journal: Japanese journal of clinical oncology
Published: December 15, 2024
Recent advances in understanding the role of sex hormone receptors in urothelial cancer.
Journal: Oncology research
Published: December 11, 2024
Last Updated: 09/26/2026